In Vivo Insulin Sensitivity and Secretion in Obese Youth
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 27 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Impaired glucose tolerance (IGT) represents a pre-diabetic state. Controversy continues in regards to its pathophysiology. The aim of this study was to investigate the differences in insulin sensitivity (IS) and secretion in obese adolescents with IGT compared with those with normal glucose tolerance (NGT) and type 2 diabetes. RESEARCH DESIGN AND METHODS—A total of 12 obese adolescents with NGT, 19 with IGT, and 17 with type 2 diabetes underwent evaluation of insulin sensitivity (3-h hyperinsulinemic [80mu/m2/min]–euglycemic clamp), first-phase insulin and second-phase insulin secretion (2-h hyperglycemic clamp), body composition, and abdominal adiposity. Glucose disposition index (GDI) was calculated as the product of first-phase insulin × insulin sensitivity. RESULTS—Insulin-stimulated glucose disposal was significantly lower in subjects with type 2 diabetes compared with subjects with NGT and IGT, with no difference between the latter two. However, compared with youth with NGT, youth with IGT have significantly lower first-phase insulin and C-peptide levels and GDI (P = 0.012), whereas youth with type 2 diabetes have an additional defect in second-phase insulin. Fasting and 2-h glucose correlated with GDI (r = −0.68, P < 0.001 and r = −0.73, P < 0.001, respectively) and first-phase insulin but not with insulin sensitivity. CONCLUSIONS—Compared with youth with NGT, obese adolescents with IGT have evidence of a β-cell defect manifested in impaired first-phase insulin secretion, with a more profound defect in type 2 diabetes involving both first- and second-phase insulin. GDI shows a significantly declining pattern: it is highest in NGT, intermediate in IGT, and lowest in type 2 diabetes. Such data suggest that measures to prevent progression or conversion from pre-diabetes to type 2 diabetes should target improvement in β-cell function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, youth with IGT are no more insulin resistant than peers with normal glucose tolerance (NGT) if matched for body composition and fat topography ( 51 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709 · cited 2×
“5% in children recruited from the community (3,4) up to 25% in youth from an obesity clinic (5).”
BackgroundResultGillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K. (2007) · BMJ · doi:10.1136/bmj.39063.689375.55 · Cited by 1,171 · cited 1×
“ported in many randomized control trials, with lifestyle intervention being at least as effective if not more effective than pharmacotherapy (16).”
BackgroundEdelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffher, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.701 · Cited by 641 · cited 2×
“Impaired glucose tolerance is a well known prediabetic state with a linear relationship between the 2hr post challenge glucose levels and subsequent risk for T2DM in adult prospective studies (1) with observed rates of progression from IGT to T2DM from 20% (13) to 60% (14,15) over an average duration of 2 to 8 years (…”
BackgroundEdelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffner, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.4.701 · Cited by 641
Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis
Knowler, W. C., Pettitt, D. J., Saad, M. F., & Bennett, P. H. (1990) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610060101 · Cited by 578 · cited 1×
“Impaired glucose tolerance is a well known prediabetic state with a linear relationship between the 2hr post challenge glucose levels and subsequent risk for T2DM in adult prospective studies (1) with observed rates of progression from IGT to T2DM from 20% (13) to 60% (14,15) over an average duration of 2 to 8 years (…”
BackgroundFerrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1133 · Cited by 540
Weiss, R., Dufour, S., Taksali, S. E., Tamborlane, W. V., Petersen, K. F., Bonadonna, R. C., Boselli, L., Barbetta, G., Allen, K., Rife, F., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14364-4 · Cited by 499 · cited 1×
“Higher insulin resistance, measured by the hyperinsulinemic-euglycemic clamp method, was reported in adolescents with IGT compared to NGT controls with no significant differences in insulin secretion (19).”
MethodThe natural history of impaired glucose tolerance in the Pima Indians
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., Mott, D. M., & Bennett, P. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192302 · Cited by 413 · cited 1×
“Impaired glucose tolerance is a well known prediabetic state with a linear relationship between the 2hr post challenge glucose levels and subsequent risk for T2DM in adult prospective studies (1) with observed rates of progression from IGT to T2DM from 20% (13) to 60% (14,15) over an average duration of 2 to 8 years (…”
Background
Research works printed but not linked: 1
- Invitti C, Gilardini L, Viberti G: Impaired glucose tolerance in obese children and adolescents. N Engl J Med 347:290–292, 2002 · DOI
Cited by
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
Insulin resistance in children: Consensus, perspective, and future directions
Levy-Marchal, C., Arslanian, S., Cutfield, W., Sinaiko, A., Druet, C., Marcovecchio, M. L., & Chiarelli, F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1047 · Cited by 405
Self-citationDynamics of insulin secretion and the clinical implications for obesity and diabetes
Seino, S., Shibasaki, T., & Minami, K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45680 · Cited by 364
Arslanian, S., Bacha, F., Grey, M., Marcus, M. D., White, N. H., & Zeitler, P. (2018) · Diabetes Care · doi:10.2337/dci18-0052 · Cited by 349
Self-citationTODAY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-2393 · Cited by 288
Mihalik, S. J., Michaliszyn, S. F., de las Heras, J., Bacha, F., Lee, S., Chace, D. H., DeJesus, V. R., Vockley, J., & Arslanian, S. A. (2012) · Diabetes Care · doi:10.2337/dc11-1577 · Cited by 251
Self-citationThe Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 235
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 222
“However, youth with IGT are no more insulin resistant than normal glucose tolerance (NGT) peers if matched for body composition and fat topography (51).”
BackgroundEffects of Bariatric Surgery on Glucose Homeostasis and Type 2 Diabetes
Bradley, D., Magkos, F., & Klein, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.114 · Cited by 152
From Pre-Diabetes to Type 2 Diabetes in Obese Youth
Bacha, F., Lee, S., Gungor, N., & Arslanian, S. A. (2010) · Diabetes Care · doi:10.2337/dc10-0004 · Cited by 138
Self-citationThe changing face of diabetes in youth: lessons learned from studies of type 2 diabetes
Hannon, T. S., & Arslanian, S. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12939 · Cited by 137
Self-citationPathophysiology of Type 2 Diabetes in Children and Adolescents
Valaiyapathi, B., Gower, B. A., & Ashraf, A. P. (2019) · Current Diabetes Reviews · doi:10.2174/1573399814666180608074510 · Cited by 191
Kim, J. Y., Bacha, F. F., Tfayli, H. M., Michaliszyn, S. F., Yousuf, S., & Arslanian, S. A. (2018) · Diabetes Care · doi:10.2337/dc18-1178 · Cited by 119
“Plasma lipid concentrations were determined using the standards of the Centers for Disease Control and Prevention (18).”
MethodSelf-citationKim, J. Y., Michaliszyn, S. F., Nasr, A., Lee, S., Tfayli, H. M., Hannon, T. S., Hughan, K. S., Bacha, F. F., & Arslanian, S. A. (2016) · Diabetes Care · doi:10.2337/dc16-0352 · Cited by 111
Self-citationBacha, F., Gungor, N., Lee, S., & Arslanian, S. A. (2013) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00915.x · Cited by 106
“Metformin and long-acting insulin were discontinued 48 h before the clamp studies as before and glycemia maintained by administration of short-acting insulin as needed up to 6 h before the clamp studies (14, 15).”
BackgroundMethodSelf-citationMichaliszyn, S. F., Mari, A., Lee, S., Bacha, F., Tfayli, H., Farchoukh, L., Ferrannini, E., & Arslanian, S. (2014) · Diabetes · doi:10.2337/db13-1951 · Cited by 92
Self-citationCardiac Abnormalities in Youth with Obesity and Type 2 Diabetes
Bacha, F. F., & Gidding, S. S. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0750-6 · Cited by 110
Self-citationSjaarda, L. G., Bacha, F., Lee, S., Tfayli, H., Andreatta, E., & Arslanian, S. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.12.050 · Cited by 90
Self-citationHannon, T. S., Kahn, S. E., Utzschneider, K. M., Buchanan, T. A., Nadeau, K. J., Zeitler, P. S., Ehrmann, D. A., Arslanian, S. A., Caprio, S., Edelstein, S. L., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13005 · Cited by 87
Self-citationMetabolomic Profiling of Amino Acids and β-Cell Function Relative to Insulin Sensitivity in Youth
Michaliszyn, S. F., Sjaarda, L. A., Mihalik, S. J., Lee, S., Bacha, F., Chace, D. H., De Jesus, V. R., Vockley, J., & Arslanian, S. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2170 · Cited by 79
Self-citationArslanian, S. A., Kim, J. Y., Nasr, A., Bacha, F. F., Tfayli, H. M., Lee, S., & Toledo, F. G. S. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12562 · Cited by 82
“Plasma lipid concentrations were determined using the standards of the Centers for Disease Control and Prevention.24 HbA1c was measured by high-performance liquid chromatography (Tosoh Medics, Inc., San Francisco, CA, USA).”
MethodSelf-citationBurns, S. F., Bacha, F., Lee, S. J., Tfayli, H., Gungor, N., & Arslanian, S. A. (2011) · Diabetes Care · doi:10.2337/dc11-0423 · Cited by 75
Self-citationThe Prevalence of Obesity Among Children With Type 2 Diabetes: A Systematic Review and Meta-analysis
Cioana, M., Deng, J., Nadarajah, A., Hou, M., Qiu, Y., Chen, S. S. J., Rivas, A., Banfield, L. E., Toor, P. P., Zhou, F., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.47186 · Cited by 92
Insulin resistance and type 2 diabetes in children
Castorani, V., Polidori, N., Giannini, C., Blasetti, A., & Chiarelli, F. (2020) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040090.045 · Cited by 68
Yu, X., Chen, H., Liang, J., Lin, Q., Tan, H., Fu, Y., Liu, X., Shan, Z., Li, X., Yang, H.-Z., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016239 · Cited by 60
“In the chronic state, high blood glucose induced by the effect of impaired glucose tolerance (IGT), especially postprandial hyperglycemia, may cause cardiac damage and dysfunction or apoptosis, eventually lead to the development of heart failure [5,6].”
BackgroundPathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon
Tfayli, H. M., & Arslanian, S. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200008 · Cited by 69
Self-citationKim, J. Y., Tfayli, H., Michaliszyn, S. F., & Arslanian, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01958 · Cited by 55
“Tanner stage (III/IV/V), n (%) 5 (24)/5 (24)/11 (52) 2 (10)/3 (14)/16 (76) 0.”
MethodSelf-citationKim, J. Y., Nasr, A., Tfayli, H. M., Bacha, F. F., Michaliszyn, S. F., & Arslanian, S. A. (2017) · Diabetes · doi:10.2337/db17-0551 · Cited by 63
Self-citationPathophysiology and treatment of prediabetes and type 2 diabetes in youth
Bacha, F., Hannon, T. S., Tosur, M., Pike, J. M., Butler, A., Tommerdahl, K. L., & Zeitler, P. S. (2024) · Diabetes Care · doi:10.2337/dci24-0029 · Cited by 57
Self-citationBacha, F., Pyle, L., Nadeau, K., Cuttler, L., Goland, R., Haymond, M., Levitsky, L., Lynch, J., Weinstock, R. S., White, N. H., et al. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00841.x · Cited by 52
“A limited number of cross-sectional pediatric studies (3–6) similarly revealed that the pathophysiology of type 2 diabetes involves both a decrease in insulin action (3, 5) as well as a β-cell secretory defect (3–6).”
BackgroundSelf-citationSjaarda, L. A., Michaliszyn, S. F., Lee, S., Tfayli, H. M., Bacha, F. F., Farchoukh, L. O., & Arslanian, S. A. (2012) · Diabetes Care · doi:10.2337/dc12-0747 · Cited by 50
Self-citationPrediabetes in Adolescents: Prevalence, Management and Diabetes Prevention Strategies
Esquivel-Zuniga, R., & DeBoer, M. D. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s284401 · Cited by 53
George, M. M., & Copeland, K. C. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0334-z · Cited by 50
“Secretion of insulin and C-peptide can be divided into two phases, first and second, using a 2h hyperglycemic clamp, and insulin-stimulated glucose disposal can be calculated using a euglycemic clamp [22].”
MethodHeras, J. D. L., Rajakumar, K., Lee, S., Bacha, F. F., Holick, M. F., & Arslanian, S. A. (2013) · Diabetes Care · doi:10.2337/dc12-1288 · Cited by 45
Self-citationBacha, F., Gungor, N., Lee, S., & Arslanian, S. A. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00820.x · Cited by 43
“009 μmol/kg/min) (Isotech, Miamisburg, OH, USA) (11).”
BackgroundMethodInfluentialSelf-citationCoronary Artery Calcification in Obese Youth: What Are the Phenotypic and Metabolic Determinants?
Bacha, F. F., Edmundowicz, D., Sutton-Tyrell, K., Lee, S., Tfayli, H. M., & Arslanian, S. A. (2014) · Diabetes Care · doi:10.2337/dc14-0193 · Cited by 43
“Most of the prediabetic and T2DM subjects have been reported in previous work related to b-cell function and IS (14,15).”
BackgroundMethodResultSelf-citationHoenig, M. E., Jordan, E. T., Ferguson, D. C., & de Vries, F. (2009) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2009.08.004 · Cited by 52
Complicaciones metabólicas de la obesidad infantil
Yeste, D., & Carrascosa, A. (2011) · Anales de Pediatría · doi:10.1016/j.anpedi.2011.03.025 · Cited by 73
Tfayli, H. M., Lee, S., Bacha, F. F., & Arslanian, S. A. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00745.x · Cited by 223
Self-citationHigh prevalence of prediabetes in a Swedish cohort of severely obese children
Ek, A. E., Rössner, S. M., Hagman, E., & Marcus, C. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12136 · Cited by 42
Glucoregulatory Physiology in Subjects with Low-Normal, High-Normal, or Impaired Fasting Glucose
Dagogo-Jack, S. E., Askari, H., & Tykodi, G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1348 · Cited by 40
Serbis, A., Giapros, V. I., Tsamis, K. I., Balomenou, F., Galli‐Τsinopoulou, A., & Siomou, E. C. (2023) · Nutrients · doi:10.3390/nu15092217 · Cited by 46
Waist-to-height ratio as a marker of low-grade inflammation in obese children and adolescents
Caminiti, C., Armeno, M. L., & Mazza, C. S. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0526 · Cited by 39
“[58, 59] found an association between inflammatory markers and waist circumference in young adults and concluded that both for CRP and for Il-6, markers of central adiposity correlated better than those that evaluate total fat mass after adjusting for age, sex, smoking, and physical exercise both in obese and in norma…”
BackgroundRocco, E. R., Mory, D. B., Bergamin, C. S., Valente, F., Miranda, V. L., Calegare, B. F. A., Silva, R. Q., & Dib, S. A. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000800020 · Cited by 39
Update on Nonautoimmune Diabetes in Children
Zeitler, P. S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0493 · Cited by 34
Measuring β-Cell Function Relative to Insulin Sensitivity in Youth
Sjaarda, L. A., Lee, S., Tfayli, H. M., Bacha, F. F., Bertolet, M. H., & Arslanian, S. A. (2012) · Diabetes Care · doi:10.2337/dc12-1508 · Cited by 37
Self-citationChen, M. E., Chandramouli, A. G., Considine, R. V., Hannon, T. S., & Mather, K. J. (2018) · Diabetes Care · doi:10.2337/dc17-1373 · Cited by 26
Yeow, T. P., Pacini, G., Tura, A., Hor, C. P., Lim, S. L., Tan, F. H. S., Tong, C. V., Hong, J. Y. H., Zain, F. M., Holst, J. J., et al. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000352 · Cited by 26
Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance
Cree‐Green, M., Wiromrat, P., Stuppy, J. J., Thurston, J. E., Bergman, B. C., Baumgartner, A., Bacon, S. D., Scherzinger, A. L., Pyle, L. L., & Nadeau, K. J. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00258.2018 · Cited by 26
“IR increases along the spectrum of glucose tolerance in adolescents with obesity without T2D (4, 35) and IR in youth to be higher compared with adults (2).”
BackgroundGlycemic Variability Is Associated with Markers of Vascular Stress in Adolescents
Dasari, P. S., Gandomani, B. S., Teague, A. M., Pitale, A., Otto, M., & Short, K. R. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.01.065 · Cited by 23
“O besity is a major risk factor for prediabetes and type 2 diabetes mellitus (T2DM) in children and adults.(1,2) The progression from insulin resistance to T2DM tends to be faster in adolescents compared with adults.”
BackgroundPediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes
Hitt, T. A., & Katz, L. E. L. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.08.003 · Cited by 24
Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone
Manu, P., Correll, C. U., Wampers, M., van Winkel, R., Yu, W., Shiffeldrim, D., Kane, J. M., & Binder, M. D. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.11.016 · Cited by 25
“A larger waist circumference is a near-universal corollary of obesity, which is associated with insulin resistance and hyperinsulinemia (Polonsky et al., 1988; Adiels et al., 2008; Bacha et al., 2009; Jill et al., 2009).”
β-Cell Dysfunction in Adolescents and Adults with Newly Diagnosed Type 2 Diabetes Mellitus
Elder, D. A., Herbers, P. M., Weis, T., Standiford, D. A., Woo, J. G., & D’Alessio, D. A. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.12.002 · Cited by 22
Kim, J. Y., Tfayli, H. M., Bacha, F. F., Lee, S., Michaliszyn, S. F., Yousuf, S., Gebara, N. Y., & Arslanian, S. A. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12940 · Cited by 22
Self-citationKim, J. Y., & Jeon, J. Y. (2020) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040140.070 · Cited by 24
Michaliszyn, S. F., Lee, S., Bacha, F. F., Tfayli, H. M., Farchoukh, L. O., Mari, A., Ferrannini, E., & Arslanian, S. A. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12364 · Cited by 20
Self-citationHughan, K. S., Bonadonna, R. C., Lee, S., Michaliszyn, S. F., & Arslanian, S. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3492 · Cited by 22
Self-citationRivera-Vega, M., Flint, A., Winger, D. G., Libman, I. M., & Arslanian, S. A. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12249 · Cited by 18
Self-citationHa, J., Chung, S. T., Springer, M., Kim, J. Y., Chen, P., Chhabra, A., Cree‐Green, M., Behn, C. D., Sumner, A. E., Arslanian, S. A., et al. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00189.2023 · Cited by 21
Self-citationIncretin Hormones: Pathophysiological Risk Factors and Potential Targets for Type 2 Diabetes
Rosenberg, J., Jacob, J., Desai, P., Park, J., Donovan, L., & Kim, J. Y. (2021) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes21053 · Cited by 20
“GLP-1 exists in several different forms: GLP-1 (1-37), or 1-36amide; and 2 truncated forms, GLP-1 (7-36) or amidated GLP-1, and GLP-1 (7-37), or extended GLP-1.”
BackgroundInfluentialPediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop
Barrett, J. S., Bucci-Rechtweg, C. M., Cheung, S. Y. A., Gamalo, M., Haertter, S., Karres, J., Marquard, J., Mulugeta, Y. A., Ollivier, C., Strougo, A., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1805 · Cited by 13
“Studies in youth with obesity and increasing degrees of dysglycemia from normoglycemia to prediabetes to T2D show, as in adults, that β-cell failure is the underlying pathophysiologic phenomenon.(21) During puberty, insulin sensitivity decreases 25–30% in healthy adolescents.”
BackgroundVidmar, A. P., Durazo-Arvizú, R., Weigensberg, M. J., Alderete, T. L., & Goran, M. I. (2023) · Diabetes · doi:10.2337/db22-1034 · Cited by 13
Carreau, A., Xie, D., Garcia‐Reyes, Y., Rahat, H., Bartlette, K., Behn, C. D., Pyle, L. L., Nadeau, K. J., & Cree‐Green, M. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13072 · Cited by 13
Insulin Dynamics and Pathophysiology in Youth-Onset Type 2 Diabetes
Abu-Nejem, R., & Hannon, T. S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae463 · Cited by 8
Pathogenesis of Insulin Resistance and Glucose Intolerance in Childhood Obesity
Weiss, R., Cali, A. M. G., & Caprio, S. (2010) · Springer eBooks · doi:10.1007/978-1-60327-874-4_13 · Cited by 5
Stevens, P., Hunter, J., & Molodysky, E. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102445 · Cited by 5
The Diagnosis of Prediabetes in Adolescents
Zdravković, V., Sajić, S., Mitrović, J., Stefanovic, I., Pavićević, P., Nikolić, D. M., Dimić, J., & Lalić, N. (2014) · Journal of Medical Biochemistry · doi:10.2478/jomb-2014-0062 · Cited by 7
“IGI, WBISI, Quicki and HOMA%B were significantly lower in the prediabetes group compared to the NGT J Med Biochem 2015; 34 (1) 41”
BackgroundResultDEPTORpromoter genetic variants and insulin resistance in obese children and adolescents
Kovač, J., Temovski, T. Š., Rozmarič, T., Horvat, S., Beltram, J., Podkrajšek, K. T., Battelino, T., & Kotnik, P. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12371 · Cited by 7
“, impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes) may have had a relevant beta-cell dysfunction and were excluded from the analysis (15, 16).”
BackgroundA Mathematical Model-Derived Disposition Index Without Insulin Validated in Youth With Obesity
Ha, J., Kim, J. Y., Springer, M., Chhabra, A., Chung, S. T., Sumner, A. E., Sherman, A., & Arslanian, S. A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae582 · Cited by 4
Self-citationLi, G., Chen, X., Liang, X., Hu, L., Zhang, L., Xu, X., Wu, W., Huang, K., Dong, G., Zhang, J., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12905 · Cited by 4
Kim, J. Y., Tfayli, H. M., Bacha, F. F., Lee, S., Gebara, N. Y., & Arslanian, S. A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154346 · Cited by 4
Self-citationEhrmann, D. A., Temple, K. A., Rue, A., Barengolts, E., Mokhlesi, B., Cauter, E. V., Sam, S., Miller, M. A., Kahn, S. E., Atkinson, K. M., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12883 · Cited by 9
Self-citationEffect of impaired glucose tolerance on cardiac dysfunction in a rat model of prediabetes.
Liang, J., Feng, Z.-K., Liu, X., Lin, Q., Fu, Y., Shan, Z., Zhu, J.-N., Shu-guang, L., & Xi-yong, Y. (2011) · PubMed · Cited by 5
Pre-diabetes in Italian obese children and youngsters.
Brufani, C., Fintini, D., Ciampalini, P., Nocerino, V., Crea, F., Giannone, G., Patera, P. I., Valerio, G., Cappa, M., & Barbetti, F. (2011) · PubMed · doi:10.3275/7798 · Cited by 3
Diabetes and learning disabilities
Phillips, A. (2009) · Practice Nursing · doi:10.12968/pnur.2009.20.12.45582 · Cited by 2
Kim, J. Y., Tfayli, H. M., Bacha, F. F., & Arslanian, S. A. (2021) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20088 · Cited by 2
Self-citationPrediabetes in children and adolescents: A ticking bomb!
Gupta, A., Choudhary, N., & Gupta, N. (2024) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v13.i2.92127 · Cited by 3
Cho, W., Bacha, F. F., Tfayli, H. M., Lee, S., Michaliszyn, S. F., Kim, J. Y., & Arslanian, S. A. (2025) · Obesity · doi:10.1002/oby.24317 · Cited by 6
“Disposition index (DI), which represents insulin secretion relative to insulin sensitivity, was calculated as the product of PIS and first-phase insulin secretion [3, 11, 12].”
InfluentialSelf-citationLi, Y.-Q., Zhang, L., Zhao, Y., Xu, F., Hu, Z., Wu, Q.-H., Li, W., & Li, Y.-N. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i11.1643 · Cited by 1
Diabetes and learning disabilities
Phillips, A. (2011) · Independent Nurse · doi:10.12968/indn.2011.20.6.84618
Tfayli, H. M., & Arslanian, S. A. (2009)
Self-citationRocco, E. R., Mory, D. B., Bergamin, C. S., Valente, F., Miranda, V. L., Silva, R. Q., & Dib, S. A. (2011)
Endocrine and Metabolic Complications of Pediatric Obesity
Bacha, F. F. (2015) · The Endocrine Society eBooks · doi:10.1210/mtp4.9781936704941.ch48
Self-citationPinhas‐Hamiel, O., Zeitler, P. S., & Kelsey, M. M. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_24
Current literature in diabetes
(2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.993
İnsülin 100 Yıllık Mucize Hormon
Cerit, E. T., Barlas, T., Atalar, K., Bahçelioğlu, M., Kaplanoğlu, G. T., Seymen, C. M., Erdem, H. B., Ergün, M. A., Demir, Ö., Gülbahar, Ö., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.871
Prediabetes: Evolution of Terminology, Global Estimates, and Diagnosis
(2021) · American Diabetes Association eBooks · doi:10.2337/9781580407625.ch02
Bacha, F. F. (2024) · Diabetes Care · doi:10.2337/dci24-0006
Self-citationYouth-Onset Type 2 Diabetes: A Review
Samaan, M. C. (2025) · Canadian Diabetes & Endocrinology Today · doi:10.58931/cdet.2025.3346
Gök, Ç. C., & Akçay, T. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02999-w
“The standard OGTT acts as a metabolic stress test, unmasking disruptions that correlate with increasing disease severity [13, 14].”
Metadata
- Authors
- Bacha, F., Gungor, N., Lee, S., & Arslanian, S. A.
- Affiliations
- Children's Hospital of Pittsburgh (US)
- Anadolu Saglik Merkezi Gebze, Kocaeli, Turkey
- Corresponding author
- Bacha, Fida
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-01-01
- Volume
- 32
- Issue
- 1
- Pages
- 100-105
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2606839
- OpenAlex
- W2160471613
- Cited by
- 90
- References
- 25
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 7 · 2016: 6 · 2015: 2 · 2014: 7 · 2013: 4 · 2012: 11
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Pittsburgh Foundation
- Thrasher Research Fund
- U.S. Public Health Service (K24 HD01357, UL1 RR024153)
- National Center for Research Resources (MO-1-RR-00084, UL1RR024153, M01RR000084)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01‐HD27503, R01HD027503, K24HD001357, K24 HD 01357)
- Children's Hospital of Pittsburgh
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin sensitivity, insulin secretion, impaired glucose tolerance, type 2 diabetes, adolescent obesity, beta-cell dysfunction, first-phase insulin secretion, second-phase insulin secretion, prediabetes, hyperinsulinemic-euglycemic clamp, hyperglycemic clamp, C-peptide, body composition, abdominal fat
- MeSH terms
- Abdomen, Insulin Secretion, Adipose Tissue, Adolescent, C-Peptide, Diabetes Mellitus, Type 2, Estradiol, Female, Glucose, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Insulin, Male, Obesity, Reference Values, Viscera, Glucose Clamp Technique, Body Mass Index, Glucose Intolerance, Dehydroepiandrosterone Sulfate, Black People, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.